NetworkNewsBreaks

ThursdayJun 16, 2022 3:54 pm

NetworkNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Leveraging Graphene Technology to Bring Distinct Products to Market

Kronos Advanced Technologies (OTC: KNOS) has built a reputation for offering some of the most effective, advanced, state-of-the-art air filtration and purification products. “In addition to air filtration systems, the company also offers Kronos(R)-designed graphene N95-compatible face masks made in the United States at a NIOSH-certified facility. Kronos recently announced test results from Nelson Labs demonstrating significant enhanced bacterial filtration efficiency (‘BFE’) and viral filtration efficiency (‘VFE’). According to the update, Kronos’-designed and U.S.-manufactured 5-ply graphene face masks remove 99.9% of bacteria and virus particles compared to the common and far less efficacious ASTM level 4 masks. The company believes…

Continue Reading

ThursdayJun 16, 2022 3:25 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Shares Replays of 2022 LD Micro Invitational Company Presentations

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, through Sequire, its SaaS platform, hosted the 2022 LD Micro Invitational. The invitation was held June 7–9, 2022, in both an in-person and virtual format; those attending in person gathered in Westlake, California. The event included 187 companies that each provided a 25-minute presentation. Those presentations are now available online. SRAX noted that some of the most viewed presentations include Cel-Sci Corporation (NYSE: CVM), NaturalShrimp Inc. (OTCQB: SHMP), 22nd Century Group Inc (NASDAQ: XXII), Humanigen Inc. (NASDAQ HGEN), and Lightwave…

Continue Reading

ThursdayJun 16, 2022 3:09 pm

NetworkNewsBreaks – ANYONE to Release ‘The Sylvia Sessions,’ a Tribute, First-Ever NFT Album Featuring the Late Taylor Hawkins

TogethermenT Records has announced the release of a new album by the critically acclaimed rock band ANYONE, featuring the late Taylor Hawkins on drums. The album entitled “The Sylvia Sessions” is slated for release on June 20 and will be available as a deluxe NFT package with exclusive video, pictures and liner notes via BandNfts.com, the NFT marketplace of BandRoyalty. “The Sylvia Sessions” is a historically significant release, and the first full album to ever be released as an NFT, showcasing the earliest recordings of Taylor Hawkins to ever be heard – recorded in 1993 and originally released as a…

Continue Reading

ThursdayJun 16, 2022 3:01 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at H.C. Wainwright 1st Annual Mental Health Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that its CEO Doug Drysdale will participate in a fireside chat and panel discussion at the H.C. Wainwright 1st Annual Mental Health Conference. The event is slated to take place at the Lotte New York Palace Hotel on June 27, 2022. Drysdale’s fireside chat will be webcast live at 10:30 a.m. ET on the day of the conference. In addition, Drysdale will participate in a panel discussion titled “Navigating Depression: Current Understanding and Future Treatments” at 12:45 p.m. ET. Interested parties should visit…

Continue Reading

ThursdayJun 16, 2022 2:45 pm

NetworkNewsBreaks – Iconic Brands Inc. (ICNB) Announces FY 2021 Results, ~74% Increase in Total Revenue

Iconic Brands (OTCQB: ICNB), a leader in the development, design and delivery of alcohol and non-alcohol beverages, today released its financial results for the full year ended Dec. 31, 2021. Among the highlights, the company reported $4,960,016 in total revenue for the fiscal year, which reflected an approximately 74% increase of $2,111,103. “2021 was a historic year for our company and one that we believe will continue to pay dividends into the future,” said Iconic Chief Executive Officer Larry Romer. “We achieved many milestones during the year and have put in place a business plan that we expect to drive…

Continue Reading

ThursdayJun 16, 2022 2:33 pm

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces $5M Share Repurchase Program

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, today announced that its board of directors has authorized the repurchase of up to $5 million of its outstanding common shares as market conditions and the company’s liquidity warrant. “We believe that the potential to repurchase our shares at these levels represents a compelling opportunity to deploy available cash to drive shareholder value,” said Luis Merchan, Flora’s chairman and CEO. “Flora continues to move assertively to execute its growth plans while simultaneously improving gross profit margins and reducing corporate overhead expenses. We are confident…

Continue Reading

ThursdayJun 16, 2022 2:13 pm

NetworkNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTC: LQWDF) Provides Corporate Update

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), an emerging technology company developing payment infrastructure for the Bitcoin Lightning Network, has reported a key corporate update. The company announced that Peter Loretto, an independent director, has resigned from his role. The company indicated that he was resigning for personal reasons. “LQwD would like to thank Mr. Loretto for his contributions, and the Board now consists of Shone Anstey, Ashley Garnot, Pino Perone and Kim Evans,” the company stated in the press release. To view the full press release, visit https://nnw.fm/eJ7NK About LQwD Fintech Corp. LQwD is a Lightning Network service provider (“LSP”) focused on developing payment infrastructure…

Continue Reading

WednesdayJun 15, 2022 3:14 pm

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Collaborating to Progress Mission to Create Safe, Effective Therapeutics

Cybin (NYSE American: CYBN) (NEO: CYBN), a clinical-stage biopharmaceutical company committed to progressing Psychedelics to Therapeutics(TM), has joined the ranks of companies dedicated to finding and offering effective solutions to those suffering from mental health conditions. “The company announced that pilot results from its sponsored feasibility study evaluating Flow, Kernel’s quantitative neuroimaging technology, indicate that ketamine-induced changes in the brain’s functional connectivity persisted for several days after receiving the substance,” a recent article reads. “The purpose of the four-week study is to evaluate the altered state of consciousness of an individual following the administration of ketamine. The Kernel Flow headset…

Continue Reading

WednesdayJun 15, 2022 2:52 pm

NetworkNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) Committed to Building on Its Holistic Approach to Mental Health Wellness

Delic Holdings (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, is devoted to finding solutions for mental ailments — not simply by easing symptoms, but by attacking the root causes of the difficulties, utilizing a toolbox of innovative, therapeutic substances. “Recently, Delic announced that six of its clinic locations will launch a specialized therapy that has the potential to boost natural energy stores and immunity, brain and DNA function, and cell communication. The NAD+ (nicotinamide adenine dinucleotide) infusion therapy is administered intravenously or intramuscularly and has previously shown evidence that such treatments support the creation of new cells, neuropathways…

Continue Reading

WednesdayJun 15, 2022 2:22 pm

NetworkNewsBreaks – Odyssey Health Inc.’s (ODYY) Novel Drug Candidate Represents a Valuable Asset

Odyssey Health (OTC: ODYY) recently completed a safety evaluation of cohort I of its phase I clinical trial administering PRV-002, the company’s novel drug treatment for concussion. “Findings from the cohort, which included eight healthy human volunteers that received a single dose of PRV-002 or placebo followed by evaluations for abnormal responses, showed that the participants did not exhibit any severe adverse events as PRV-002 was well tolerated,” a recent article reads. “The completion of the safety evaluation is the latest milestone as the company journeys toward providing concussion treatment… With the phase I clinical trial, which consists of 48…

Continue Reading